FDA Lifts Hold on Clinical Trials of Intrathecal OAV-101 & Self-Acceptance and Rejecting Ableism

FDA Lifts Hold on Clinical Trials of Intrathecal OAV-101 & Self-Acceptance and Rejecting Ableism

SMA News Today’s multimedia associate, Price Wooldridge, discusses the FDA lifting its partial hold on clinical trials of Intrathecal OAV-101 for the treatment of Spinal Muscular Atrophy (SMA). Also, forums Director Kevin Schaefer reads a story from our 31 Days of SMA series. This piece, written by Tristram Peters, is about self-acceptance and rejecting ableism. Link to 31 Days of SMA series: https://smanewstoday.com/category/31-days-of-sma/ Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/

Jaksot(444)

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
voi-hyvin-meditaatiot-2
psykopodiaa-podcast
tiedenaiset-podcast
vakeva-elama-viisaampi-mieli-vahvempi-keho
puhu-muru
katilon-kahvitunti
rss-pitaisko-erota
meditaatiot-suomeksi
rss-pt-paahtio
audio-sport-juoksu
rss-kuumilla-aalloilla
terapiassa
selviytyjat-tarinoita-elamasta
junnut-pelissa
rss-mighty-finland-podcast
paritellen
rss-nautinto
rss-narsisti
rss-kyykkya-ja-kuoharia